Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域:
Cancer
Target:
IC50: 2.2 nM (PLK1), 9.1 nM (PLK3)[1]
描述:
GW843682X is a selective, ATP-competitive inhibitor of PLK1 and PLK3, with IC50 of 2.2 nM and 9.1 nM, respectively, and is also >100-fold selective against ~30 other kinases.